First Reliance Bk SC (FSRL) 5.0500 $FSRL /C O R R E C T

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Reliance Bk SC (FSRL) 5.0500 $FSRL

/C O R R E C T I O N -- First Reliance Bancshares, Inc./
PR Newswire - Fri Jun 03, 9:01AM CDT
In the news release, First Reliance Makes Partial Redemption of TARP Preferred And Notices Intent to Redeem All Remaining Shares Outstanding, issued Jun 3, 2016 by First Reliance Bancshares, Inc. over PR Newswire, we are advised by the company that the fourth paragraph, second sentence, should read "is expected to positively impact earnings per share on an annual basis by $0.21 per share, or approximately $977,000 additional net income to common stockholders" rather than "$0.16 per share, or approximately $733,000" as originally issued inadvertently. The complete, corrected release follows:

First Reliance Makes Partial Redemption of TARP Preferred And Notices Intent to Redeem All Remaining Shares Outstanding
PR Newswire - Fri Jun 03, 6:00AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL), the holding company (the "Company" for First Reliance Bank (the "Bank", announced that it made a partial redemption of 4,000 shares, or 26.1 % of its 15,349 shares of outstanding Fixed Rate Cumulative Perpetual Preferred Stock, Series A ("Series A Preferred Stock" that were originally issued to the United States Department of the Treasury ("U.S. Treasury" under the Troubled Asset Relief Program Capital Purchase Program ("TARP". In March 2013, the U.S. Treasury sold all 15,349 shares of Series A Preferred Stock and Fixed Rate Cumulative Perpetual Preferred Stock, Series B ("Series B Preferred Stock" previously held by it to private investors. The redemption price for the shares of Series A Preferred Stock was $1,000 per share, plus accrued and unpaid dividends. The total aggregate redemption prices of the shares of Series A Preferred Stock was $4 million.

First Reliance reports 1Q16 Pre-tax Income of $820,221, up 53.1% from 1Q15
PR Newswire - Wed May 11, 6:58AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL), the holding company (the "Company" for First Reliance Bank (the "Bank", reported first quarter 2016 pre-tax profits of $820,221. This is the 9th consecutive quarter of profitability which has been fueled by strong loan and deposit growth, and expanding operating efficiencies. In the first quarter of 2016, pre-tax income is up 53.1% over $535,733 in the first quarter a year ago. Net income totaled $514,138 for the quarter ended March 31, 2016, compared to $513,426 as of March 31, 2015. After preferred dividends, first quarter 2016 net income available to common shareholders was $147,499, or $0.03 per diluted share, compared to $150,816, or $0.03 per diluted share, in the first quarter a year ago.

First Reliance 3Q15 Pre-tax Income more than Triples to $997,430 from 3Q14
PR Newswire - Fri Oct 30, 6:00AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL), the holding company (the "Company" for First Reliance Bank (the "Bank", reported third quarter 2015 pre-tax profits reached the highest levels since 2008, fueled by strong loan and deposit growth, and expanding operating efficiencies. In the third quarter of 2015, pre-tax income more than tripled to $997,430 from $234,117 in the third quarter a year ago. Net income totaled $670,574 for the quarter ended September 30, 2015, compared to $3.4 million, which includes a deferred tax asset recapture of $3.6 million for the third quarter of 2014. After preferred dividends, third quarter 2015 net income available to common shareholders was $307,964, or $0.07 per diluted share, compared to $3.1 million, or $0.66 per diluted share, in the third quarter a year ago.

First Reliance Announces Strong 2nd Quarter Results
PR Newswire - Fri Jul 31, 6:00AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL) announced that it had net income of $7.0 million for the quarter ended June 30, 2015. This compares to a net income of $372,331 for the quarter ended June 30, 2014. The increase in net income is largely attributed to a deferred tax asset recapture of $6.9 million. Additionally, the Company had one-time credit and mortgage charges of $585,000 during the quarter ended June 30, 2015. Net income for six months ended June 30, 2015 was $7.5 million. This compares to net income of $718,689 for the six months ended June 30, 2014. Operating results were positively impacted by asset growth of $13 million since December 31, 2014 through robust retail and correspondent mortgage production and continued consumer loan and 1-4 family mortgage originations.

First Reliance Bancshares declares preferred stock and trust preferred securities dividends
M2 - Wed Jun 17, 3:45AM CDT
First Reliance Bancshares Inc (OTC:FSRL) revealed on Tuesday the return to cash dividend payments on its preferred stock originally issued to the US Treasury as part of the Troubled Asset Relief Program (TARP) and now held by private investors, besides, interest on its outstanding trust preferred securities.

First Reliance Bancshares, Inc. Announces Return to Payment of Dividends on Preferred Stock and Trust Preferred Securities
PR Newswire - Tue Jun 16, 5:00AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL), the parent holding company of First Reliance Bank, announced today the return to cash payment of dividends on the Company's preferred stock originally issued to the United States Treasury as part of the Troubled Asset Relief Program (TARP) and now held by private investors, and interest on the Company's outstanding trust preferred securities. The Company had been in deferral on these payments since November 2011.

First Reliance Announces Strong 1st Quarter Results
PR Newswire - Thu Apr 30, 5:30AM CDT
First Reliance Bancshares, Inc. (OTC: FSRL) announced that it had net income of $513,427, for the quarter ended March 31, 2015. This compares to a net income of $346,357, for the quarter ended March 31, 2014. The increase in net income from March 31, 2014 to March 31, 2015 is primarily attributed to an increase in net interest income of $217,673, supported by no-cost/low-cost annual deposit growth of $10.3 million, and an increase in noninterest income of $142,481. The Company's operating results for the quarter were positively impacted by annual asset growth of $8.2 million, annual consumer loan growth of $5.4 million, and annual non performing asset reduction of $3.7 million.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 280

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 161

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 224

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 170

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 177

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Insights on Rising Breast Cancer in Younger Women

Updated Category News Views 204

Understanding the Alarming Trends in Breast Cancer Recent research has uncovered concerning statistics regarding breast cancer in younger women, specifically those aged 18 to 49. A comprehensive study conducted across multiple outpatient facilities has revealed a significant portion of breast cancer diagnoses among this demographic, raising urgent questions about current...

Continue Reading
Asseta: Transforming Family Office Management with AI Solutions

Updated Category News Views 2347

Asseta Unveils Its Rebrand and Advanced AI Offerings In a significant development, Prismatic has rebranded to become Asseta, a transformation that underscores its dedication to providing innovative financial management solutions tailored specifically for family offices. This transition not only marks a shift in branding but signals a deeper commitment to enhancing the...

Continue Reading
Understanding Microsoft's Recent Options Activity and Trends

Updated Category News Views 124

The Surge in Microsoft Options Trading Investors with substantial capital have adopted a bullish approach towards Microsoft (NASDAQ: MSFT). This trend is essential for both institutional and retail traders alike to grasp their positions in the market. What Unusual Trading Movements Reveal Today, a noteworthy surge in options trades for Microsoft caught our attention...

Continue Reading
Eilean Therapeutics Expands Clinical Trials with ZE74-0282 Innovation

Updated Category News Views 103

Eilean Therapeutics Progresses ZE74-0282 into Clinical Trials Eilean Therapeutics has announced an exciting advancement in their pipeline with the development of ZE74-0282, now entering its first-in-human clinical trials. This innovative treatment aims to battle myeloproliferative neoplasms, particularly focusing on the JAK2 V617F mutated variant that poses significant...

Continue Reading
Supermicro's Open Storage Summit Highlights AI's Storage Revolution

Updated Category News Views 236

Supermicro's Open Storage Summit: A Game Changer The Open Storage Summit, hosted by Super Micro Computer, Inc. (SMCI), is gearing up to make waves in the tech industry. This year marks the sixth installment of the summit, which will be running from August 12 to August 28, featuring nine insightful sessions and the participation of 23 companies and 40 speakers. The event...

Continue Reading